RNF38 encodes a nuclear ubiquitin protein ligase that modifies p53

Biochemical and Biophysical Research Communications

Volumn 440, Issue 4, 2013, Pages 473-478

  Sheren, Jamie E ^a   Kassenbrock, C Kenneth ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

E3; p53; PML nuclear bodies; RNF38; Ubiquitin protein ligase

Indexed keywords

PROTEIN P53; RNF38 PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; UBIQUITINATION;

EID: 84887070132     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.08.031     Document Type: Article

References (31)

1. D.P. Lane P53, guardian of the genome Nature 358 1992 15 16
2. A.J. Levine, and M. Oren The first 30 years of p53: growing ever more complex Nat. Rev. Cancer 9 2009 749 758
3. S.A. Forbes, N. Bindal, S. Bamford, C. Cole, C.Y. Kok, D. Beare, M. Jia, R. Shepherd, K. Leung, A. Menzies, J.W. Teague, P.J. Campbell, M.R. Stratton, and P.A. Futreal COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer Nucl. Acids Res. 39 2010 D945 D950
4. D. Walerych, M. Napoli, L. Collavin, and G. Del Sal The rebel angel: mutant p53 as the driving oncogene in breast cancer Carcinogenesis 33 2012 2007 2017
5. A. Petitjean, E. Mathe, S. Kato, C. Ishioka, S.V. Tavtigian, P. Hainaut, and M. Olivier Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database Hum. Mutat. 28 2007 622 629
6. Y. Zhang, and Y. Xiong Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53 Mol. Cell 3 1999 579 591
7. A.S. Coutts, C.J. Adams, and N.B. La Thangue P53 ubiquitination by Mdm2: a never ending tail? DNA Repair 8 2009 483 490
8. Y.-S. Jung, Y. Qian, and X. Chen Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy FEBS Lett. 586 2012 1397 1402
9. A. Lunardi, G. Di Minin, P. Provero, M. Dal Ferro, M. Carotti, G. Del Sal, and L. Collavin A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network Proc. Natl. Acad. Sci. USA 107 2010 6322 6327
10. I. Eisenberg, H. Hochner, T. Levi, R. Yelin, T. Kahan, and S. Mitrani-Rosenbaum Cloning and characterization of a novel human gene RNF38 encoding a conserved putative protein with a RING finger domain Biochem. Biophys. Res. Commun. 294 2002 1169 1176
11. X.-L. Yin, A.B.-Y. Hui, J.C.-S. Pang, W.S. Poon, and H.-K. Ng Genome-wide survey for chromosomal imbalances in ganglioglioma using comparative genomic hybridization Cancer Genet. Cytogenet. 134 2002 71 76
12. S.K. Kim, J.Y. Ro, B.L. Kemp, J.S. Lee, T.J. Kwon, K.M. Fong, Y. Sekido, J.D. Minna, W.K. Hong, and L. Mao Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer Cancer Res. 57 1997 400 403
13. L. Girard, S. Zöchbauer-Müller, A.K. Virmani, A.F. Gazdar, and J.D. Minna Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering Cancer Res. 60 2000 4894 4906
14. C.T. Liew, H.M. Li, K.W. Lo, C.K. Leow, W.Y. Lau, L.Y. Hin, B.K. Lim, P.B.S. Lai, J.Y.H. Chan, X. Wang, S. Wu, and J.C.K. Lee Frequent allelic loss on chromosome 9 in hepatocellular carcinoma Int. J. Cancer 81 1999 319 324
15. E.P. Nacheva, D. Brazma, A. Virgili, J. Howard-Reeves, A. Chanalaris, K. Gancheva, M. Apostolova, M. Valgañon, H. Mazzullo, and C. Grace Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia BMC Genomics 11 2010 41
16. K.L. Lorick, J.P. Jensen, S. Fang, A.M. Ong, S. Hatakeyama, and A.M. Weissman RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination Proc. Natl. Acad. Sci. USA 96 1999 11364 11369
17. C.A. Joazeiro, and A.M. Weissman RING finger proteins: mediators of ubiquitin ligase activity Cell 102 2000 549 552
18. M.H. Kubbutat, S.N. Jones, and K.H. Vousden Regulation of p53 stability by Mdm2 Nature 387 1997 299 303
19. Y. Haupt, R. Maya, A. Kazaz, and M. Oren Mdm2 promotes the rapid degradation of p53 Nature 387 1997 296 299
20. S. Fang, J.P. Jensen, R.L. Ludwig, K.H. Vousden, and A.M. Weissman Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53 J. Biol. Chem. 275 2000 8945 8951
21. A. Laine, and Z. Ronai Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1 Oncogene 26 2007 1477 1483
22. R.P. Leng, Y. Lin, W. Ma, H. Wu, B. Lemmers, S. Chung, J.M. Parant, G. Lozano, R. Hakem, and S. Benchimol Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation Cell 112 2003 779 791
23. D. Dornan, I. Wertz, H. Shimizu, D. Arnott, G.D. Frantz, P. Dowd, K. O'Rourke, H. Koeppen, and V.M. Dixit The ubiquitin ligase COP1 is a critical negative regulator of p53 Nature 429 2004 86 92
24. S. Kosugi, M. Hasebe, M. Tomita, and H. Yanagawa Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs Proc. Natl. Acad. Sci. USA 106 2009 10171 10176
25. A.N. Nguyen Ba, A. Pogoutse, N. Provart, and A.M. Moses NLStradamus: a simple Hidden Markov Model for nuclear localization signal prediction BMC Bioinf. 10 2009 202
26. D.R. O'Reilly P53 and transformation by SV40 Biol. Cell 57 1986 187 196
27. V. Fogal, M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P.P. Pandolfi, H. Will, C. Schneider, and G. Del Sal Regulation of p53 activity in nuclear bodies by a specific PML isoform EMBO J. 19 2000 6185 6195
28. H. Shen, and C.G. Maki P53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and nutlin-3a-treated U2OS cells J. Cell. Biochem. 111 2010 1280 1290
29. S. Laín, C. Midgley, A. Sparks, E.B. Lane, and D.P. Lane An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs Exp. Cell Res. 248 1999 457 472
30. W.-Q. Jiang, L. Szekely, G. Klein, and N. Ringertz Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line Exp. Cell Res. 229 1996 289 300
31. M. Gostissa, T.G. Hofmann, H. Will, and G. Del Sal Regulation of p53 functions: let's meet at the nuclear bodies Curr. Opin. Cell Biol. 15 2003 351 357